VISIT THHEALTHCARE.COM - The Healthcare & Life Sciences division of Technology Holdings

Technology Holdings advises SUAZIO, A Data-Driven Life Sciences and MedTech Strategic Consultancy, on its strategic sale to NAMSA

Mar 2023
Technology Holdings is pleased to announce that it has acted as the exclusive financial advisor to SUAZIO, a leading data-driven Life Sciences and MedTech consultancy on its strategic sale to NAMSA, the world's leading MedTech CRO, an Archimed portfolio company headquartered in the United States.
Has been acquired by

Life Sciences & MedTech Consulting

View Transaction Details
Technology Holdings advises SUAZIO, A Data-Driven Life Sciences and MedTech Strategic Consultancy, on its strategic sale to NAMSA
Seller SUAZIO
Buyer NAMSA
Focus Sector Life Sciences & MedTech Consulting
Date March 2023

Technology Holdings is pleased to announce that it has acted as the exclusive financial advisor to SUAZIO, a leading data-driven Life Sciences and MedTech consultancy on its strategic sale to NAMSA, the world's leading MedTech CRO, an Archimed portfolio company headquartered in the United States.

quote TH’s impressive track record in the Life Sciences Consulting, Data Science and Digital Transformation spaces was evident through their extensive network of industry buyer and investor relationships and deep understanding of the landscape. Their structured and highly professional sale process, combined with strategic insights and connections to key players in the industry, resulted in numerous offers. Their hard work and commitment to success resulted in an outcome that exceeded our expectations both in terms of valuation and fit. TH did the heavy lifting throughout the process, from creating compelling materials, facilitating extensive buyer/investor meetings, to managing due diligence and negotiations. The team was always responsive and worked hard to negotiate the optimal valuation and structure while guiding us through all the complexities and challenges of the process and consistently providing us with clear advice at each stage. TH truly became an extension of the SUAZIO team, just as they promised! NAMSA's strong heritage in the Life Sciences ecosystem makes them an excellent partner for us.
Christophe Van der Linden Founder & CEO, SUAZIO

Founded in 2001 and headquartered in Antwerp, Belgium, with a presence in key European, North American and APAC markets, SUAZIO provides highly specialized data-driven market research, insights, analytics, and consulting services in the Life Sciences and MedTech markets. SUAZIO has developed a research-based, end-to-end ecosystem of complementary consulting services and methodologies for life sciences clients in 5 domains: Customer insights, Product value drivers, Patient journey, Digital healthcare & Economic value proposition. SUAZIO has long term relationships with leading life sciences and medical device companies.

With the acquisition of SUAZIO, NAMSA deepens its research and product development capabilities and increases its global presence to 20 locations across the Americas, Asia and Europe. Dr Christophe Berthoux, CEO of NAMSA said “NAMSA is very enthusiastic about expanding its global strategic consulting services with the addition of SUAZIO. Client insights and precise market research are what power the true value of novel medical technologies and product acceptance. With the SUAZIO Team, NAMSA will expand its client reach even further and strengthen the delivery of its end-to-end development services to the global MedTech industry.”

Christophe Van der Linden, CEO of SUAZIO echoed “With similar values and expertise in providing insights to accelerate MedTech innovation, our services are well-aligned to truly deliver global clients end-to-end development and commercialization solutions that lead to success.”

Vivek Subramanyam, Founder and CEO of Technology Holdings said, “We are proud to have advised SUAZIO on this landmark Life Sciences and MedTech transaction. Christophe and his team have built a truly market leading data driven strategic consultancy. This transaction is our 16th deal in the healthcare and life sciences ecosystem and further demonstrates our expertise as industry leaders in the space. SUAZIO’s capabilities and team are exceptional and we wish them every success in this strategic partnership with NAMSA.”

Group 9
Transactions
Group 9
Apr 2024
Has been acquired by

Financial Services Management Consulting

View Transaction Details
Mar 2024
Has been acquired by

Marketing Automation

View Transaction Details
Technology Holdings advises The Lumery, a leading MarTech consultancy, on its strategic sale to Accenture
Feb 2024
Majority acquired by

Insurance Technology Services & IP

View Transaction Details
Technology Holdings advises InsurTech specialist Aggne, on the acquisition of a majority stake by Wipro for $66 Million
Dec 2023
Has been acquired by

Salesforce Consulting & IP

View Transaction Details
Technology Holdings advises ForeFront, a Salesforce Summit Partner, on its strategic sale to NEORIS
Nov 2023
Has been acquired by

ServiceNow Consulting & Managed Services

View Transaction Details
Technology Holdings advises ServiceNow Elite Partner Unifii on its strategic sale to Bain Capital backed Inetum
Nov 2023
Has been acquired by

Management Consulting & Digital Transformation

View Transaction Details
Technology Holdings advises Management Consulting led Digital Transformation Specialist, WINNING Consulting on its strategic sale to Alan Allman Associates
Nov 2023
Has been acquired by

Digital Transformation Agency

View Transaction Details
Technology Holdings advises Digital Transformation Agency, Cyber-Duck on its strategic sale to CACI
Oct 2023
Private Equity Buyout

B2B Marketing Services & Marketing Automation

View Transaction Details
Technology Holdings advises B2B Marketing & Marketing Automation Specialist, Quarry on its sale to private equity fund, RTC Partners
Aug 2023
Has been acquired by

Fintech Software Engineering

View Transaction Details
Technology Holdings advises Woodridge Software, a Fintech Software Development Company, on its sale to RCG Global Services
Jun 2023
Has been acquired by

Software Engineering, Telco & Embedded Systems

View Transaction Details
Technology Holdings advises DEK Technologies, a Software Engineering and Embedded Systems Specialist, on its strategic sale to Endava
May 2023
Has been acquired by

Life Sciences Commercialization & Marketing

View Transaction Details
Technology Holdings advises The Kinetix Group, a Life Sciences Commercialization and Marketing company, on its sale to Petauri Health
Apr 2023
Technology Holdings is pleased to announce that it has acted as the exclusive financial advisor to AIOPSGROUP, a digital commerce specialist on its strategic sale to valantic, a Munich-headquartered digital solutions, consulting and software company with more than 500 large clients, including 32 of the 40 listed German blue chips.
Has been acquired by
TECHNOLOGY HOLDINGS ADVISES AIOPSGROUP, A DIGITAL COMMERCE, SALESFORCE AND AIOPS SPECIALIST, ON ITS STRATEGIC SALE TO VALANTIC

Digital Commerce, Salesforce & AIOPs

View Transaction Details
Technology Holdings advises AIOPSGROUP, a Digital Commerce, Salesforce and AIOPs specialist, on its strategic sale to valantic
Mar 2023
Technology Holdings is pleased to announce that it has acted as the exclusive financial advisor to SUAZIO, a leading data-driven Life Sciences and MedTech consultancy on its strategic sale to NAMSA, the world's leading MedTech CRO, an Archimed portfolio company headquartered in the United States.
Has been acquired by

Life Sciences & MedTech Consulting

View Transaction Details
Technology Holdings advises SUAZIO, A Data-Driven Life Sciences and MedTech Strategic Consultancy, on its strategic sale to NAMSA
Feb 2023
Has been acquired by

Hyperautomation, BPM, AI & Data Science

View Transaction Details
Technology Holdings advises Humans4Help, a Hyperautomation, AI & Data Science Specialist, on its strategic sale to Alan Allman Associates